Key references

  1. Bullet64-slice or higher computed tomography angiography as an alternative to invasive coronary angiography in the investigation of coronary artery disease.pdf

  2. Bullet2014 AHA:ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes.pdf

  3. Bullet2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.pdf

  4. Bullet2017 ACC:AHA Focused Update Guideline for the Management of Heart Failure - American College of Cardiology.pdf

  5. BulletA Multicenter Randomized Trial Assessing the Efficacy of Helium:Oxygen in Severe Exacerbations of Chronic Obstructive Pulmonary Disease.pdf

  6. BulletA reappraisal of loop diuretic choice in heart failure patients Review 2015.pdf

  7. BulletA Tale of Coronary Artery Disease and Myocardial Infarction.pdf

  8. BulletACC 2012 Expert Consensus Document on Troponin Elevations.pdf

  9. BulletACC focused update on STEMI and PCI 2009.pdf

  10. BulletACC:AHA Challenges in Infective Endocarditis.pdf

  11. BulletACC:AHA Coronary Revascularization in Patients With Acute Coronary Syndromes 2016.pdf.pdf

  12. BulletACC:AHA Guidelines Abdominal aortic aneurysm.pdf

  13. BulletACC:AHA Guidelines Acute Coronary Syndromes -Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.pdf

  14. BulletACC:AHA Guidelines Early management of ischemic stroke.pdf

  15. BulletACC:AHA Guidelines Heart Failure.pdf

  16. BulletACC:AHA Guidelines Infective Endocarditis in Adults 2015.pdf

  17. BulletACC:AHA Guidelines Management of adults with congenital heart disease.pdf

  18. Bullet ACC:AHA Guidelines Management of intracerebral hemorrhage.pdf

  19. Bullet ACC:AHA Guidelines Management of SAH.pdf

  20. BulletACC:AHA Guidelines Perioperative evaluation and care for non cardiac surgery.pdf

  21. BulletACC:AHA Guidelines ST elevation MI 2007 Update.pdf

  22. Bullet ACC:AHA Guidelines Unstable angina non-ST elevation MI 2007.pdf

  23. BulletACC:AHA Guidelines Valvular heart disease 2014.pdf

  24. BulletACC:AHA Management of Cardiogenic Shock Review 2017.pdf

  25. BulletACCF:AHA 2013 Guideline for the Management of ST-Elevation Myocardial Infarction.pdf

  26. BulletACCF:AHA Guideline for the Management of Heart Failure 2013.pdf

  27. BulletAccidental Hypothermia review 2012.pdf

  28. BulletACCP thrombosis 9th ed Antiplatelet Drugs.pdf

  29. BulletACCP thrombosis 9th ed Antithrombotic and Thrombolytic Therapy for Ischemic Stroke.pdf

  30. BulletACCP thrombosis 9th ed Antithrombotic Therapy for Atrial Fibrillation.pdf

  31. BulletACCP thrombosis 9th ed Antithrombotic Therapy in Peripheral Artery Disease.pdf

  32. BulletACCP thrombosis 9th ed Approach to Outcome Measurement in the Prevention of Thrombosis in Surgical and Medical Patients.pdf

  33. BulletACCP thrombosis 9th ed Diagnosis of DVT.pdf

  34. BulletACCP thrombosis 9th ed Evidence-Based Management of Anticoagulant Therapy.pdf

  35. BulletACCP thrombosis 9th ed introduction.pdf

  36. BulletACCP thrombosis 9th ed New Antithrombotic Drugs.pdf

  37. BulletACCP thrombosis 9th ed Oral Anticoagulant Therapy.pdf

  38. BulletACCP thrombosis 9th ed Parenteral Anticoagulants.pdf

  39. BulletACCP thrombosis 9th ed Perioperative Management of Antithrombotic Therapy.pdf

  40. BulletACCP thrombosis 9th ed Prevention of VTE in Nonorthopedic Surgical Patients.pdf

  41. BulletACCP thrombosis 9th ed Prevention of VTE in Nonsurgical Patients.pdf

  42. BulletACCP thrombosis 9th ed Prevention of VTE in Orthopedic Surgery Patients.pdf

  43. BulletACCP thrombosis 9th ed Primary and Secondary Prevention of Cardiovascular Disease.pdf

  44. BulletACCP thrombosis 9th ed summary.pdf

  45. BulletACCP thrombosis 9th ed Treatment and Prevention of Heparin-Induced Thrombocytopenia.pdf

  46. BulletACCP thrombosis 9th ed VTE Antithrombotic Therapy for VTE Disease.pdf

  47. BulletACCP thrombosis 9th ed VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy.pdf

  48. BulletACEI and kidneys.pdf

  49. BulletAcetazolamide for Obstructive and Central Sleep Apnea 2020.pdf

  50. BulletAcetyl Cysteine importance of dose and route of administration.pdf

  51. BulletAcetylcysteine and creatinine levels.pdf

  52. BulletAcetylcysteine to prevent contrast ARF 2.pdf

  53. BulletAcetylcysteine to prevent contrast ARF.pdf

  54. BulletAcquisition of Antibiotic-Resistant Bacteria by U.S. International Travelers.pdf

  55. BulletActivation of coagulation system during air travel.pdf

  56. BulletAcute alcohol toxicity and withdrawal in the emergency room and medical admissions unit.pdf

  57. BulletAcute altitude illnesses review 2011.pdf

  58. BulletAcute Coronary Syndrome letters.pdf

  59. BulletAcute coronary syndrome without ST segment elevation.pdf

  60. BulletAcute exacerbation in interstitial Lung Disease.pdf

  61. BulletAcute Exacerbation of Idiopathic Pulmonary Fibrosis Review.pdf

  62. BulletAcute heart failure.pdf

  63. BulletAcute High-Altitude Illnesses review 2013.pdf

  64. BulletAcute Kidney Injury and Chronic Kidney Disease as Interconnected Syndromes Review 2014.pdf

  65. BulletAcute Kidney Injury in Patients with Cancer Review 2017.pdf

  66. BulletAcute kidney injury review 2013.pdf

  67. BulletAcute Management of Atrial Fibrillation.pdf

  68. BulletAcute MI Review.pdf

  69. BulletAcute Myocardial Infarction after Laboratory-Confirmed Influenza Infection 2018.pdf

  70. BulletAcute Myocardial Infarction and Left Bundle-Branch Block -- Can We Lift the Veil.pdf

  71. BulletAcute myocardial infarction review 2017.pdf

  72. BulletAcute Myocardial Infarction review.pdf

  73. BulletAcute myocardial infarction survival UK vs Sweden.pdf

  74. BulletAcute Pericarditis.pdf

  75. Bulletacute pneumonia and the cardiovascular system review 2013.pdf

  76. BulletAcute renal failure an unacceptable death sentence globally.pdf

  77. BulletAcute Stroke Intervention Review 2015.pdf

  78. BulletAcute treatment of ischaemic stroke Review 2018.pdf

  79. BulletAddressing liver disease in the UK 2014.pdf

  80. BulletAdrenal insufficiency.pdf

  81. BulletAdrenaline for anaphyl.pdf

  82. BulletAdult obstructive sleep apnoea review 2014.pdf

  83. BulletAdults with Congenital Heart Disease Review.pdf

  84. BulletAdvances in Clinical Cardiology 2018.pdf

  85. BulletAdvances in Sleep apnoea review.pdf

  86. BulletAggressive diuresis in acute heart failure.pdf

  87. BulletAir Versus Oxygen in ST-Segment–Elevation Myocardial Infarction.pdf

  88. BulletAirway Mucus Function and Dysfunction.pdf

  89. BulletAlcoholic hepatitis review.pdf

  90. BulletAldosterone Antagonists in Heart Failure.pdf

  91. BulletAldosterone in ccf.pdf

  92. BulletAlpha1 Antitrypsin deficiency.pdf

  93. BulletAminoglycoside versus carbapenem or piperacillin:tazobactam treatment for bloodstream infections of urinary source caused by Gram-negative ESBL-producing Enterobacteriaceae.pdf

  94. BulletAtrial Fibrillation Review.pdf

  95. BulletAmiodarone-induced pneumonitis.pdf

  96. BulletAn alarming rise in incidence of infective endocarditis in England since 2009.pdf

  97. BulletANCA review.pdf

  98. BulletAnemia of Chronic Disease.pdf

  99. BulletAngina-Syndrome X.pdf

  100. BulletAngiotensin Converting Enzyme 2 A Double-Edged Sword.pdf

  101. BulletAngiotensin-Neprilysin Inhibition and Renal Outcomes in Heart Failure with Preserved Ejection Fraction.pdf

  102. BulletAngiotensin–Neprilysin Inhibition in Acute Decompensated Heart Failure.pdf

  103. BulletAngiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.pdf

  104. BulletAnkle-brachila index for assessment of peripheral arterial disease.pdf

  105. BulletAnother Decade, Another Coronavirus.pdf

  106. BulletAnswers to Common Questions About the Use and Safety of CT Scans.pdf

  107. BulletAntibacterial Activity of Ticagrelor in Conventional Antiplatelet Dosages Against Antibiotic-Resistant Gram-Positive Bacteria letter.pdf

  108. BulletAntibiotic allergy.pdf

  109. BulletAntibiotic prophylaxis for SBE.pdf

  110. BulletAntimicrobial Stewardship Toolkit for English Hospitals.PDF

  111. BulletAntiphospholipid syndrome.pdf

  112. BulletAntiplatelet strategies in ageing patients with acute coronary syndromes.pdf

  113. BulletAntiplatelet therapy after coronary stenting for how long.pdf

  114. BulletAntithrombin alternatives in STEMI.pdf

  115. BulletAntithrombotic therapy for heart valves Review.pdf

  116. BulletAortic regurgitation.pdf

  117. BulletAortic Stenosis review.pdf

  118. BulletAortic Valve Stenosis review 2014.pdf

  119. BulletArm ischemia cardiac pre condition.pdf

  120. BulletAspergillosis.pdf

  121. BulletAspiration Pneumonia and Related Syndromes Review 2018.pdf

  122. BulletAspirin and the Prevention of Venous Thromboembolism.pdf

  123. BulletAspirin-Exacerbated Respiratory Disease Review 2016 .pdf

  124. BulletAspirin-Exacerbated Respiratory Disease.pdf

  125. BulletAspirin—still the GLOBAL LEADER in antiplatelet therapy.pdf

  126. BulletAssessment and management of massive haemoptysis.pdf

  127. BulletAssociation Between Early Recovery of Kidney Function After Acute Kidney Injury and Long-term Clinical Outcomes 2020.pdf

  128. BulletAssociation is not causation treatment effects cannot be estimated from observational data in heart failure.pdf

  129. BulletAssociation of Inferior Vena Cava Filter Placement for Venous Thromboembolic Disease and a Contraindication to Anticoagulation With 30-Day Mortality.pdf

  130. BulletAsthma treatment review.pdf

  131. BulletAtheroembolic renal disease.pdf

  132. BulletAtheroma in soldiers autopsied from Korean, Viet Nam and Iraq War.pdf

  133. BulletAtherosclerosis Opie.pdf

  134. BulletAtrial fibrillation review 2012.pdf

  135. BulletAtrial fibrillation Review 2016.pdf

  136. BulletAtrial Fibrillation review Opie.pdf

  137. BulletAvoidance of high concentration oxygen in chronic obstructive pulmonary disease copy.pdf

  138. BulletAzithromycin and the Risk of Cardiovascular Death.pdf

  139. BulletAzithromycin With Mortality and Cardiovascular Events Among Older Patients Hospitalized With Pneumonia.pdf

  140. BulletB-Natriuretic Peptide in Detecting Diastolic Dysfunction.pdf

  141. BulletBacterial Diarrhea Review.pdf

  142. BulletBacterial meningitis review 2012.pdf

  143. BulletBeta blockers in heart failure edit.pdf

  144. BulletBiomarkers in Heart Failure - Review.pdf

  145. BulletBiomarkers in heart failure.pdf

  146. BulletBiomarkers in kidney and heart disease.pdf

  147. BulletBiventricular Pacing.pdf

  148. BulletBlood Trans and MI.pdf

  149. BulletBlood Transfusion for Gastrointestinal Bleeding.pdf

  150. BulletBNP a useful tool for the detection of acute pulmonary artery embolism.pdf

  151. BulletBNP and CCF.pdf

  152. BulletBNP and troponin in risk stratification in pulmonary embolism review.pdf

  153. BulletBNP in CCF.pdf

  154. BulletBrain Abscess review 2014.pdf

  155. BulletBraunwald Overview of AF-Related Strokes  2011.pdf

  156. BulletBritish Asthma Guidelines 2014.pdf

  157. BulletBTS guidelines for the insertion of a chest drain.pdf

  158. BulletBTS guidelines for the management of malignant pleural effusions.pdf

  159. BulletBTS guidelines for the management of pleural infection.pdf

  160. BulletCABG versus PTCA.pdf

  161. BulletCancer Workup after Unprovoked Clot.pdf

  162. BulletCarbohydrate-Deficient Transferrin .pdf

  163. BulletCardiac Arrest after an Acute Myocardial Infarction.pdf

  164. BulletCardiac catheterization.pdf

  165. BulletCardiac Drugs-ACE inhibitors and ARBs.pdf

  166. BulletCardiac Drugs-Antiarrhythmic drugs.pdf

  167. BulletCardiac Drugs-Antihypertensive therapies.pdf

  168. BulletCardiac Drugs-Antithrombotic agents Platelet inhibitors acute anticoagulants fibrinolytics.pdf

  169. BulletCardiac Drugs-Beta blocking agents.pdf

  170. BulletCardiac Drugs-Calcium channel blockers.pdf

  171. BulletCardiac Drugs-Diuretics.pdf

  172. BulletCardiac Drugs-Drugs for the Heart.pdf

  173. BulletCardiac Drugs-Heart Failure.pdf

  174. BulletCardiac Drugs-Lipid modifying and antiatherosclerotic drugs.pdf

  175. BulletCardiac Drugs-Metabolic syndrome and type 2 diabetes.pdf

  176. BulletCardiac Drugs-Nitrates.pdf

  177. BulletCardiac dysfunction during exacerbations of chronic obstructive pulmonary disease Review 2016.pdf

  178. BulletCardiac enzymes.pdf

  179. BulletCardiac Failure, Kidney Dysfunction, and Kidney Injury Intersect in Cardiorenal Syndrome.pdf

  180. BulletCardiac myosin activation - omecamtiv mecarbil.pdf

  181. BulletCardiac Pacing -review.pdf

  182. BulletCardiac Resynchronization Therapy for Treatment of Heart Failure.pdf

  183. BulletCardiac Resynchronization Therapy.pdf

  184. BulletCardio-renal syndromes.pdf

  185. BulletCardiogenic shock due to Acute mitral regurgitation.pdf

  186. BulletCardiohepatic Interactions in Heart Failure review 2013.pdf

  187. BulletCardioprotection review 2013.pdf

  188. BulletCardiorenal syndrome.pdf

  189. BulletCardiorenal syndrome and acute heart failure.pdf

  190. BulletCardiorenal Syndrome Edit.pdf

  191. BulletCardiorenal Syndrome review.pdf

  192. BulletCardiorenal Syndrome Revisited.pdf

  193. BulletCardioselective b-Blockers on Mortality in Patients with Chronic Obstructive Pulmonary Disease and Atherosclerosis.pdf

  194. BulletCardiovascular remodelling in coronary artery disease and heart failure review 2014.pdf

  195. BulletCardiovascular Risk, Myocardial Injury, and Exacerbations of Chronic Obstructive Pulmonary Disease.pdf

  196. BulletCardiovascular Risks with Antibacterial Drugs.pdf

  197. BulletCare of the Asplenic Patient.pdf

  198. BulletCause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis Review 2017.pdf

  199. BulletCauses and Imaging Patterns of Tree-in-Bud Opacities.pdf

  200. BulletCephalosporins in Penicillin allergy.pdf

  201. BulletCerebral Intraparenchymal Hemorrhage Review 2019.pdf

  202. BulletCerebral Oxygenation in Patients With OSA Effects of Hypoxia at Altitude and Impact of Acetazolamide.pdf

  203. BulletChemotherapy for Tuberculous Meningitis.pdf

  204. BulletChest Pain and Supplemental Oxygen.pdf

  205. BulletChest pain with normal angio.pdf

  206. BulletChikungunya Review.pdf

  207. BulletChronic kidney disease review 2012.pdf

  208. BulletChronic kidney disease Review 2017.pdf

  209. BulletChronic obstructive pulmonary disease review 2012.pdf

  210. BulletCirrhosis in HCV: Fibroscan, King's Score and Liver Biopsy.pdf

  211. BulletCirrhosis review 2015.pdf

  212. BulletCirrhosis Review.pdf

  213. BulletClinical manifestations and diagnosis of stress (takotsubo) cardiomyopathy.pdf

  214. BulletClinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy.pdf

  215. BulletClinical features of patients infected with 2019 novel coronavirus in Wuhan 2020.pdf

  216. BulletClinician’s Guide to Reducing Inflammation to Reduce Atherothrombotic Risk 2019.pdf

  217. BulletClopidogrel Pharmacogenetics.pdf

  218. BulletClostridium difficile Infection Review 2015.pdf

  219. BulletCommunity Acquired Pneumonia.pdf

  220. BulletCommunity-Acquired Pneumonia and cardiac events.pdf

  221. BulletCommunity-Acquired Pneumonia in Adults.pdf

  222. BulletCommunity-acquired pneumonia Pathogenesis of acute cardiac events and potential adjunctive therapies.pdf

  223. BulletCommunity-Acquired Pneumonia Requiring Hospitalization.pdf

  1. BulletCommunity-Acquired Pneumonia Review 2014 (2).pdf

  2. BulletCommunity-Acquired Pneumonia Review 2014.pdf

  3. BulletCommunity-acquired pneumonia Review 2015.pdf

  4. BulletCommunity-acquired pneumonia.pdf

  5. BulletComorbidities and Subgroups of Patients Surviving Severe Acute Hypercapnic Respiratory Failure in the Intensive Care Unit.pdf

  6. BulletComparative Effectiveness of Carotid Endarterectomy vs Initial Medical Therapy in Patients With Asymptomatic Carotid Stenosis 2020.pdf

  7. BulletComparative Effectiveness of Diuretic Regimens in CCF.pdf

  8. BulletComparison of methods for estimating glomerular filtration rate in critically ill patients with acute kidney injury.pdf

  9. BulletCompeting Risk of Cardiac Status and Renal Function During Hospitalization for Acute Decompensated Heart Failure.pdf

  10. BulletComputed tomography of the chest.pdf

  11. BulletContrast CT Scans in the Emergency Department Do Not Increase Risk of Adverse Renal Outcomes.pdf

  12. BulletContrast induced ARF.pdf

  13. BulletContrast Induced Nephropathy - distal Ischemic Preconditioning for Prevention.pdf

  14. BulletContrast induced nephropathy in vascular surgery 2016.pdf

  15. BulletContrast induced nephropathy.pdf

  16. BulletContrast-Associated Acute Kidney Injury Review 2019.pdf

  17. BulletContrast-Induced Acute Kidney Injury Review 2016.pdf

  18. BulletContrast-induced nephropathy following angiography and cardiac interventions.pdf

  19. BulletContrast-Induced Nephropathy Review 2015.pdf

  20. BulletContrast-Induced Nephropathy Review.pdf

  21. BulletContribution of External Forces to Left Ventricular Diastolic Pressure.pdf

  22. BulletControversies in cardiogenic shock.pdf

  23. BulletCOPD and FEV Edit.pdf

  24. BulletCOPD in non smokers.pdf

  25. BulletCOPD pathophysiol.pdf

  26. BulletCOPD Review.pdf

  27. BulletCoronary artery disease physiology and prognosis.pdf

  28. BulletCoronary intervention radial artery access comes of age.pdf

  29. BulletCoronary interventions 2018.pdf

  30. BulletCOPD pathophysiol.pdf

  31. BulletCoronary revascularization edit.pdf

  32. BulletCoronavirus Infections.pdf

  33. BulletCorrelation and Prognostic Utility of B-Type Natriuretic Peptide and Its Amino-Terminal Fragment in Patients With Chronic Kidney Disease.pdf

  34. BulletCorticosteroids and pneumonia.pdf

  35. BulletCould a New Method to Detect Coronary Inflammation Prevent Heart Attacks?.pdf

  36. BulletCPAP in Obstructive Sleep Apnea.pdf

  37. BulletCrises in Sickle Cell Disease Review 2016.pdf

  38. BulletCrohn’s disease review 2012.pdf

  39. BulletCrohn’s disease Review 2017.pdf

  40. BulletCroup Review.pdf

  41. BulletCRT in heart failure with a narrow QRS.pdf

  42. BulletCryoglobulinaemias Review.pdf

  43. BulletCryoglobulinemia vasculitis.pdf

  44. BulletCVA.pdf

  45. BulletDeep vein thrombosis review.pdf

  46. BulletDelirium Tremens Review 2014.pdf

  47. BulletDengue and its effects on liver.pdf

  48. BulletDengue Review 2019.pdf

  49. BulletDengue.pdf

  50. BulletDeterminants of the decline in mortality from acute myocardial infarction in England.pdf

  51. BulletDetrimental role of humoral signalling in cardio-renal cross-talk.pdf

  52. BulletDiagnosing HFpEF.pdf

  53. BulletDiagnosing MI using troponin T.pdf

  54. BulletDiagnosis and management of cellulitis.pdf

  55. BulletDiagnosis and Management of Heart Failure with Preserved Ejection Fraction 10 Key Lessons.pdf

  56. BulletDiagnosis and Management of Idiosyncratic Drug-Induced Liver Injury guidelines 2014.pdf

  57. BulletDiagnosis of reversible causes of coma Review 2014.pdf

  58. BulletDiagnosis of Tuberculosis in Adults and Children guideline 2016.pdf

  59. BulletDiagnostic imaging review 2012.pdf

  60. BulletDialysis and iodinated contrast media.pdf

  61. BulletDialysis Review 2016.pdf

  62. BulletDiaphragmatic dysfunction review.pdf

  63. BulletDiastolic heart failure.pdf

  64. BulletDigoxin use in atrial fibrillation.pdf

  65. BulletDiscord Over Contrast-Induced Nephropathy.pdf

  66. BulletDilated cardiomyopathy Review 2017.pdf

  67. BulletDiuretic Treatment in Heart Failure Review 2017.pdf

  68. BulletDo natruiuretic peptides have a role in chronic renal failure.pdf

  69. BulletDoes hemofiltration protect against contrast induced renal failure?.pdf

  70. BulletDoes This Patient Have an Exudative Pleural Effusion.pdf

  71. BulletDrowning review 2012.pdf

  72. BulletDrug eluting coronary artery stents review 2013.pdf

  73. BulletDrug eluting stents edit..pdf

  74. BulletDrug eluting stents Edt.pdf

  75. BulletDrug eluting stents review.pdf

  76. BulletDual antiplatelet therapy post CABG?why not a radial artery instead?.pdf

  77. BulletDual antiplatelet treatment after stenting.pdf

  78. BulletDuration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Patients With and Without Acute Coronary Syndrome Review 2016.pdf

  79. BulletEarly Invasive Versus Selective Strategy for Non–ST-Segment Elevation Acute Coronary Syndrome ICTUS trial.pdf

  80. BulletEarly Surgery versus Conventional Treatment for Infective Endocarditis.pdf

  81. BulletEffect of Alteplase Within 6 Hours of Acute Ischemic Stroke on All-Cause Mortality.pdf

  82. BulletEfficacy and safety outcomes of recanalisation procedures in patients with acute symptomatic pulmonary embolism.pdf

  83. BulletEmergency Treatment of Asthma Review.pdf

  84. BulletEmpirical MRSA Coverage for Nonpurulent Cellulitis.pdf

  85. BulletEndovascular Therapy for Stroke.pdf

  86. BulletEpidemiology, Antibiotic Therapy, and Clinical Outcomes in Health Care–Associated Pneumonia.pdf

  87. BulletEpidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure.pdf

  88. BulletEpilepsy Review 2015.pdf

  89. BulletERCP for Gallstone Pancreatitis.pdf

  90. BulletESC 2012 Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.pdf

  91. BulletESC Guidelines for the management of infective endocarditis 2015.pdf

  92. BulletEsophageal Varices.pdf

  93. BulletEssential hypertension review.pdf

  94. BulletEstimating the Risk of Radiocontrast-Associated Nephropathy.pdf

  95. BulletEuropean guideline  use of new oral anticoagulants in patients with non valvular atrial fibrillation 2013.pdf

  96. BulletEuropean Society of Cardiology 2016 Guidelines for the diagnosis and treatment of acute and chronic heart failure.pdf

  97. BulletEvaluation and Initial Treatment of Supraventricular Tachycardia.pdf

  98. BulletEvaluation of abnormal liver enzymes review.pdf

  99. BulletEvaluation of acute chest pain review.pdf

  100. BulletEvaluation of Patients With Suspected Acute Pulmonary embolism.pdf

  101. BulletEXAMINATION of new drug eluting stents edit.pdf

  102. BulletExtracorporeal Ultrafiltration for Fluid Overload in Heart Failure.pdf

  103. BulletExtrapulmonary TB.pdf

  104. BulletFactor VIIa and ICH.pdf

  105. BulletFactor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis.pdf

  106. BulletFatal cases of Chikungunya virus infection in Colombia.pdf

  107. BulletFine tuning for Acute coronary syndromes.pdf

  108. BulletFluid removal in acute heart failure diuretics versus devices Review 2014.pdf

  109. BulletFractional Flow Reserve Measurement for the Physiological Assessment of Coronary Artery Stenosis Severity.pdf

  110. BulletFrom Creatine Kinase-MB to Troponin.pdf

  111. BulletFundamentals of Lung Auscultation.pdf

  112. BulletGenetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel.pdf

  113. BulletGroup B streptococcus review.pdf

  114. BulletGuidelines for management of atrial fibrillation 2011.pdf

  115. BulletGuidelines for management of catheter associated urinary tract infections.pdf

  116. BulletGuidelines for the Early Management of Patients With Acute Ischemic Stroke 2013.pdf

  117. BulletGuidelines for the Management of Spontaneous Intracerebral Hemorrhage 2015.pdf

  118. BulletGuidelines for the Management of Spontaneous Intracerebral Hemorrhage.pdf

  119. BulletGuidelines for the management of tumour lysis syndrome in adults and children with haematological malignancies 2015.pdf

  120. BulletGuillain Barre.pdf

  121. BulletHAPE 2.pdf

  122. BulletHAPE Review 2003.pdf

  123. BulletHAPE.pdf

  124. BulletHeart failure and biomarkers.pdf

  125. BulletHeart failure and chronic obstructive pulmonary disease Review.pdf

  126. BulletHeart failure does it matter whether LVEF is reduced.pdf

  127. BulletHeart failure guidelines 2019.pdf

  128. BulletHeart failure in chronic kidney disease 2019.pdf

  129. BulletHeart Failure Review 09.pdf

  130. BulletHeart Failure review 2011.pdf

  131. BulletHeart failure review.pdf

  132. BulletHeart Failure With Preserved Ejection Fraction A Kidney Disorder.pdf

  133. BulletHeart Failure with Preserved Ejection Fraction.pdf

  134. BulletHeart failure.pdf

  135. BulletHeatstroke Review 2019.pdf

  136. BulletHemodynamic Study of Pulmonary Hypertension in Sickle Cell Disease.pdf

  137. BulletHemodynamic-guided fluid administration for the prevention of contrast-induced acute kidney injury.pdf

  138. BulletHemofiltration and contrast induced renal failure letter.pdf

  139. BulletHemorrh Stroke guidelines 07.pdf

  140. BulletHeparin and bleeding risk.pdf

  141. BulletHeparin prophylaxis has no benefit in medical patients.pdf

  142. BulletHepato Pulmonary syndrome.pdf

  143. BulletHigh altitude illness review.pdf

  144. BulletHigh-Altitude Medicine review.pdf

  145. BulletHigh-altitude medicine.pdf

  146. BulletHigh sensitivity Troponin assay.pdf

  147. BulletHow Big Are Coronary Atherosclerotic Plaques That Rupture.pdf

  148. BulletHow Safe Is Safe Enough for Space and Health Care?.pdf

  149. BulletHow Should We Sequence the Treatments for Heart Failure and a Reduced Ejection Fraction? Review 2021.pdf

  150. BulletHypercalcemia.pdf

  151. BulletHypertension Review 2015.pdf

  152. BulletHypertension review  Opie.pdf

  153. BulletHypertrophic cardiomyopathy review 2013.pdf

  154. BulletHypertrophic Cardiomyopathy.pdf

  155. BulletHyponatraemia review 2007.pdf

  156. BulletHyponatremia review.pdf

  157. BulletHypoparathyroidism Review 2019.pdf

  158. BulletHypoxia of the renal medula and treatment .pdf

  159. BulletIdentifying the lowest effective dose of acetazolamide for the prophylaxis of acute mountain sickness 2.pdf

  160. BulletIdiopathic Pulmonary Fibrosis (IPF).pdf

  161. BulletImaging of coronary inflammation for cardiovascular risk prediction.pdf

  162. BulletImmunosuppressive Drugs for Kidney Transplantation.pdf

  163. BulletImpact of Renal Disease on Natriuretic Peptide.pdf

  164. BulletImpaired Systolic Function by Strain Imaging in Heart Failure With Preserved Ejection Fraction.pdf

  165. BulletImportance of Venous Congestion for Worsening of Renal Function in Advanced Decompensated Heart Failure.pdf

  166. BulletImported Malaria in Countries where Malaria Is Not Endemic.pdf

  167. BulletIncreased Central Venous Pressure Is Associated With Impaired Renal Function.pdf

  168. BulletInfections of Cardiovascular Implantable Electronic Devices review 2012.pdf

  169. BulletInfective endocarditis guidelines 2007.pdf

  170. BulletInfective Endocarditis Review 2014.pdf

  171. BulletInfective endocarditis Review 2015.pdf

  172. BulletInfective Endocarditis.pdf

  173. BulletInflammation as a Treatment Target after Acute Myocardial Infarction 2019.pdf

  174. BulletInflammatory Bowel Disease Review.pdf

  175. BulletInflammatory bowel disease.pdf

  176. BulletInfluence of Renal Function on the Usefulness of N-Terminal Pro-B-Type Natriuretic Peptide as a Prognostic Cardiac Risk Marker in Patients Undergoing Noncardiac Vascular Surgery.pdf

  177. BulletInfluenza review 2017.pdf

  178. BulletInfluenza update 2018–2019 100 years after the great pandemic.pdf

  179. BulletInhaled and intravenous treatment in acute severe and life threatening asthma review 2012.pdf

  180. BulletInterpretation of Abnormal Liver Chemistries in the Hospitalized Patient.pdf

  181. BulletInterstitial Lung Disease and Pulmonary Fibrosis Review 2018.pdf

  182. BulletIntracerebral haemorrhage Review 2018.pdf

  183. BulletIntracerebral hemorrhage review.pdf

  184. BulletIntracranial atherosclerosis review 2014.pdf

  185. BulletIntravenous N-Acetylcysteine Improves Transplant-Free Survival in Early Stage Non-Acetaminophen Acute Liver Failure.pdf

  186. BulletIs there a role for ultrafiltration in heart failure.pdf

  187. BulletIsosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction.pdf

  188. BulletIvabradine and outcomes in chronic heart failure.pdf

  189. BulletJet lag Review.pdf

  190. BulletLaboratory Assessment of the Anticoagulant Activity of Direct Oral Anticoagulants Review 2017.pdf

  191. BulletLate thrombosis with drug eluting stents.pdf

  192. BulletLead Toxicity from a Retained Bullet.pdf

  193. BulletLevosimendan review.pdf

  194. BulletLife and death in a Wuhan coronavirus ICU.pdf

  195. BulletLiver cirrhosis review 2014.pdf

  196. BulletLiver cirrhosis review.pdf

  197. BulletLong-term albumin in cirrhosis 2018.pdf

  198. BulletLong-Term Outcomes of Acute Heart Failure Review 2017.pdf

  199. BulletLongevity Gene KLOTHO and Alzheimer Disease.pdf

  200. BulletLower Mortality Rate in Elderly Patients With Community-Onset Pneumonia on Treatment With Aspirin.pdf

  201. BulletLower resp infection Review.pdf

  202. BulletLung Anatomy.pdf

  203. BulletLung cancer review.pdf

  204. BulletMalaria Case report.pdf

  205. BulletMalaria review 2013.pdf

  206. BulletManagement of Acute Bleeding from a Peptic Ulcer Review.pdf

  207. BulletManagement of acute upper gastrointestinal bleeding Review 2019.pdf

  208. BulletManagement of drug-resistant tuberculosis Review 2019.pdf

  209. BulletManagement of infective endocarditis review 2012.pdf

  210. BulletManagement of severe pulmonary arterial hypertension.pdf

  211. BulletManagement of Sickle Cell Disease review 2014.pdf

  212. BulletManagement of Spontaneous Pneumothorax.pdf

  213. BulletManagement of Stroke 07.pdf

  214. BulletManagement of Stroke 07.pdf

  215. BulletManagement of the Cardiorenal Syndrome in Decompensated Heart Failure Reveiw 2014.pdf

  216. BulletManaging Carotid Stenosis.pdf

  217. BulletManaging Massive Hemoptysis Review 2019.pdf

  218. BulletMechanism of thrombogenesis in Atrial fibrillation.pdf

  219. BulletMechanisms of Acute Coronary Syndromes review 2013.pdf

  220. BulletMedical and Surgical Treatment of Parapneumonic Effusions.pdf

  221. BulletMeta analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality .pdf

  222. BulletMeta analysis of NAC in ARF.pdf

  223. BulletMeta-analysis of N-acetylcysteine in contrast-induced nephrotoxicity.pdf

  224. BulletMetabolic Acidosis in CKD.pdf

  225. BulletMethicillin resistant Staphylococcus Aureus.pdf

  226. BulletMitral Regurgitation Review.pdf

  227. BulletMitral stenosis review.pdf

  1. BulletMitral valve prolapse review.pdf

  2. BulletMode of Death in Heart Failure With Preserved Ejection Fraction.pdf

  3. BulletMonitoring Risk in Approved Drugs.pdf

  4. BulletMountain sickness dose of acetazolamide.pdf

  5. BulletMountain sickness, retinal haemorrhages and acclimatisation on Mount Everest in 1975.pdf

  6. BulletMultidrug-resistant pathogens in hospitalised patients coming from the community with pneumonia.pdf

  7. BulletMultiple Myeloma Review 2016.pdf

  8. BulletMyasthenia gravis.pdf

  9. BulletMyocarditis review 2012.pdf

  10. BulletMyocarditis review.pdf

  11. BulletNatriuretic peptides and cardio-renal disease.pdf

  12. BulletNatriuretic Peptides review.pdf

  13. BulletNatural-History Study of Coronary Atherosclerosis.pdf

  14. BulletNDM 1 cause for concern.pdf

  15. BulletNeprilysin Inhibition  A Novel Therapy for Heart Failure.pdf

  16. BulletNephrotic syndrome.pdf

  17. BulletNew Concepts in Diastolic Dysfunction and Diastolic Heart Failure.pdf

  18. BulletNew diagnostic strategies for pul embolism Edit.pdf

  19. BulletNew treat COPD.pdf

  20. BulletNew Troponin T assay.pdf

  21. BulletNitroglycerin and Nitric Oxide History.pdf

  22. BulletNon-alcoholic fatty liver disease Review 2015.pdf

  23. BulletNonculprit Lesions — Innocent or Guilty by Association.pdf

  24. BulletNormotensive Ischemic Acute Renal Failure.pdf

  25. BulletNovel coronavirus infection during the 2019–2020 epidemic preparing intensive care units.pdf

  26. BulletNSAIDs for high-risk patients none, celecoxib, or naproxen?.pdf

  27. BulletNSTEMI edit.pdf

  28. BulletObstructive Sleep Apnea in Adults 2019.pdf

  29. BulletOptimal management of Acute MI Edit.pdf

  30. BulletOral antiplatelet and anticoagulant treatments Review 2015.pdf

  31. BulletOral Factor Xa inhibitors.pdf

  32. BulletOrganising pneumonia.pdf

  33. BulletOseltamivir treatment for influenza in adults.pdf

  34. BulletOtotoxicity of antibiotics.pdf

  35. BulletOutcomes after Angiography with Sodium Bicarbonate and Acetylcysteine 2018.pdf

  36. BulletOxygen induced hypercapnia in COPD myths and facts.pdf

  37. BulletOSA and CV consequences review.pdf

  38. BulletOxygen therapy in COPD.pdf

  39. BulletOxygen therapy.pdf

  40. BulletParsing an enigma aspirin resistance.pdf

  41. BulletPathogenic Gut Flora Tied to Heart Failure Severity.pdf

  42. BulletPathology of Drug Eluting Stents in Humans Delayed Healing and Late Thrombotic Risk.pdf

  43. BulletPathology of fatal perioperative myocardial infarction.pdf

  44. BulletPathophysiology of Heart Failure.pdf

  45. BulletPathophysiology of ST-segment elevation myocardial infarction.pdf

  46. BulletPCI or CABG Edit.pdf

  47. BulletPCI versus CABG.pdf

  48. BulletPentoxifylline for the treatment of severe alcoholic hepatitis.pdf

  49. BulletPeptic ulcer disease Review 2017.pdf

  50. BulletPeptic ulcer disease review.pdf

  51. BulletPercutaneous closure of atrial appendage.pdf

  52. BulletPhosphodisesterase inhibitors in Pulmonary hypertension.pdf

  53. BulletPlatelet Activation Is Associated With Myocardial Infarction in Patients With Pneumonia.pdf

  54. BulletPleural Effusion .pdf

  55. BulletPneumoccoal pneumonia Review.pdf

  56. BulletPneumocystis Pneumonia review.pdf

  57. BulletPneumocystis pneumonia.pdf

  58. BulletPolymyalgia rheumatica Review 2017.pdf

  59. BulletPortal hypertension Review.pdf

  60. BulletPost-splenectomy and hyposplenic states Review 2011.pdf

  61. BulletPosterior-Wall Myocardial Infarction.pdf

  62. BulletPotassium Homeostasis Review 2015.pdf

  63. BulletPractical guidance on the use of sacubitril:valsartan for heart failure.pdf

  64. BulletPrasugrel versus Clopidogrel for Acute Coronary Syndromes without Revascularization.pdf

  65. BulletPredicting 30-Day Mortality for Patients With Acute Heart Failure.pdf

  66. BulletPortal Hypertension and varices.pdf

  67. BulletPrediction of severe community acquired pneumonia review 2012.pdf

  68. BulletPrednisolone or Pentoxifylline for Alcoholic Hepatitis.pdf

  69. BulletPrevalence of atherosclerosis among US servicemen.pdf

  70. BulletPrevalence of Pulmonary Embolism in Acute Exacerbations of COPD.pdf

  71. BulletPreventative measures for contrast induced acute renal failure review.pdf

  72. BulletPrevention of contrast-induced renal dysfunction.pdf

  73. BulletPreventing contrast nephropathy.pdf

  74. BulletPreventing Heart Failure and Improving Survival with CRT.pdf

  75. BulletPreventing major gastrointestinal bleeding in elderly patients.pdf

  76. BulletPrevention of Contrast-Associated Acute Kidney Injury.pdf

  77. BulletPrevention of mortality from Hepatitis B and C.pdf

  78. BulletPrognosis of heart failure.pdf

  79. BulletProlonged antiplatelet therapy after drug-eluting stents.pdf

  80. BulletProphylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy.pdf

  81. BulletProphylactic platelet transfusionplus supportive care versus supportive care alone in adults with dengue and thrombocytopenia.pdf

  82. BulletProphylaxis against Venous Thromboembolism in Ambulatory Patients with Cancer.pdf

  83. BulletProphylaxis for infective endocarditis.pdf

  84. BulletProtective Cardiovascular Effect of Sleep Apnea Severity in Obesity Hypoventilation Syndrome.pdf

  85. BulletProtocol for the prevention of contrast-induced renal dysfunction.pdf

  86. BulletPul Compications of sickle cell.pdf

  87. BulletPulmonary Embolism in Patients with Unexplained Exacerbation of Chronic Obstructive Pulmonary Disease.pdf

  88. BulletPulmonary hypertension review 2013.pdf

  89. BulletPulmonary hypertension.pdf

  90. BulletPulmonary injury associated with Amiodarone.pdf

  91. BulletRadiological imaging in acute ischaemic stroke.pdf

  92. BulletRapid Molecular Detection of Tuberculosis.pdf

  93. BulletRate control in AF Edit.pdf

  94. BulletRedefining Heart Failure With a Reduced Ejection Fraction.pdf

  95. BulletRelationship between QRS duration and LV mass and volume.pdf

  96. BulletRelationship of treatment delays and mortality in patients undergoing fibrinolysis and primary percutaneous coronary intervention.pdf

  97. BulletRemote ischaemic conditioning Review 2015.pdf

  98. BulletRemote ischaemic preconditioing.pdf

  99. BulletRemote ischaemic preconditioning Pathogenesis.pdf

  100. BulletRemote ischemic preconditioning edit.pdf

  101. BulletRemote Ischemic Preconditioning for Intestinal and Pulmonary Protection .pdf

  102. BulletRemote Ischemic Preconditioning on Kidney Injury.pdf

  103. BulletRemote Ischemic Preconditioning Protects the spinal cord.pdf

  104. BulletRemote ischemic preconditioning.pdf

  105. BulletRemote preconditioning and all-cause mortality.pdf

  106. BulletReninAngio System.pdf

  107. BulletResponding to medical emergencies during airflight.pdf

  108. BulletRestoring the Right Ventricle.pdf

  109. BulletRheumatoid arthritis review.pdf

  110. BulletRight Ventricular Failure Review 2019.pdf

  111. BulletRight Ventricular Function in Cardiovascular Disease.pdf

  112. BulletRight Ventricular Infarction Review.pdf

  113. BulletRisk asociated with aprotinin.pdf

  114. BulletRisk of coronary angiography.pdf

  115. BulletRollophylline adenosine antagonist and renal failure.pdf

  116. BulletRoutine angioplasty after fibrinolysis Edit.pdf

  117. BulletSerelaxin recombinant human relaxin for treatment of acute heart failure.pdf

  118. BulletSleep Apnea Syndrome.pdf

  119. BulletSecond-Generation Drug-Eluting Coronary Stents edit.pdf

  120. BulletSickle Cell Disease Review 2010.pdf

  121. BulletSickle Cell Disease Review 2017.pdf

  122. BulletSickle cell disease review.pdf

  123. BulletSimple pharmacological prophylaxis for post-ERCP pancreatitis.pdf

  124. BulletSmoking review.pdf

  125. BulletSnake bite review.pdf

  126. BulletSnakebite.pdf

  127. BulletSociety’s failure to protect a precious resource antibiotics.pdf

  128. BulletSomatostatin.pdf

  129. BulletSplenectomy and infection.pdf

  130. BulletST-segment Elevation Myocardial Infarction Review 2013.pdf

  131. BulletStage 4 chronic renal disease.pdf

  132. BulletStent thrombosis and restenosis The Andreas Gruntzig Lecture.pdf

  133. BulletStents review.pdf

  134. BulletStratifying Risk Factors for Multidrug-Resistant Pathogens in Hospitalized Patients Coming From the Community With Pneumonia.pdf

  135. BulletStroke and VII.pdf

  136. BulletStroke clinical update 07.pdf

  137. BulletStroke in Sickle Cell.pdf

  138. BulletStroke Review.pdf

  139. BulletSudden cardiac death in dialysis patients.pdf

  140. BulletSupraventricular tachycardia back to basics.pdf

  141. BulletSupraventricular tachycardia review 2012.pdf

  142. BulletSurvival with Cardiac-Resynchronization Therapy in Mild Heart Failure.pdf

  143. BulletSystemic Lupus Erythematosus Review.pdf

  144. BulletSystolic and Mean Pulmonary Artery Pressures.pdf

  145. BulletSystolic heart failure Review 2016.pdf

  146. BulletSystolic Heart Failure.pdf

  147. BulletTako-Tsubo cardiomyopathy.pdf

  148. BulletTB Review 2011.pdf

  149. BulletTB Review.pdf

  150. BulletTemporary Inferior Vena Cava Filters.pdf

  151. BulletThe ‘Ten Commandments’ for the 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.pdf

  152. BulletThe Acute Stroke Care Revolution.pdf

  153. BulletThe broken promise of remote ischaemic conditioning 2019.pdf

  154. BulletThe cardiorenal problem.pdf

  155. BulletThe case of digoxin in atrial fibrillation and heart failure.pdf

  156. BulletThe cost to the CNS of climbing to extremely high altitudes-Hornbein.pdf

  157. BulletThe diagnostic accuracy of the natriuretic peptides in heart failure.pdf

  158. BulletThe Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure.pdf

  159. BulletThe Effect of Renal Dysfunction on BNP, NT-ProBNP, and Their Ratio.pdf

  160. BulletThe great influenza pandemic of 1918–1919.pdf

  161. BulletThe Gut Microbiota Strikes Again.pdf

  162. BulletThe microbiome of uncontacted Amerindians.pdf

  163. BulletThe potential harm of oxygen therapy in medical emergencies.pdf

  164. BulletThe Right Ventricle Pulmonary Circulation Unit Review.pdf

  165. BulletThe Risks of Living Kidney Donation.pdf

  166. BulletThe Shear Stress of Busting Blood Clots.pdf

  167. BulletThe year in cardiology 2015 acute coronary syndromes.pdf

  168. BulletTherapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies.pdf

  169. BulletThird and fourth heart sounds and ventricular function.pdf

  170. BulletThird Universal Definition of Myocardial Infarction.pdf

  171. BulletThree vs Twelve Months of Dual Antiplatelet Therapy After Zotarolimus-Eluting Stents.pdf

  172. BulletThrombophilia Testing and Venous Thrombosis.pdf

  173. BulletThyrotoxicosis Review 2019.pdf

  174. BulletThyrotoxicosis review.pdf

  175. BulletTicagrelor or Prasugrel in Patients with Acute Coronary Syndromes.pdf

  176. BulletTime to Treatment in Patients with STEMI.pdf

  177. BulletTiming of Antibiotics and Outcomes for Patients Hospitalized With Community Acquired Pneumonia.pdf

  178. BulletTiming of Intervention in Non-ST Elevation Acute Coronary Syndromes.pdf

  179. BulletTranscatheter Aortic Valve Replacement.pdf

  180. BulletTranscatheter aortic valve replacement: Indications and periprocedural management.pdf

  181. BulletTranscatheter Aortic-Valve Replacement with a Balloon- Expandable Valve in Low-Risk Patients.pdf

  182. BulletTransfusion after acute upper gastrointestinal haemorrhage.pdf

  183. BulletTransjugular Intrahepatic Portosystemic Shunt.pdf

  184. BulletTreatment Algorithms for Staphylococcal Bacteremia.pdf

  185. BulletTreatment associated inflammatory deterioration in tuberculous meningitis.pdf

  186. BulletTreatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis.pdf

  187. BulletTreatment of acute coronary syndrome NSTEMI Review 2011.pdf

  188. BulletTreatment of acute coronary syndrome STEMI Review 2012.pdf

  189. BulletTreatment of alcoholic hepatitis Review.pdf

  190. BulletTreatment of Atrial Fibrillation review.pdf

  191. BulletTreatment of bronchiolitis Edit.pdf

  192. BulletTreatment of isch stroke review.pdf

  193. BulletTreatment of Left Main Coronary Artery Disease.pdf

  194. BulletTreatment of paracetamol overdose.pdf

  195. BulletTreatment of Patients with Cirrhosis Review 2016.pdf

  196. BulletTreatment of Stroke.pdf

  197. BulletTreatment of Tuberculosis Review 2015.pdf

  198. BulletTreatment of von Willebrandts disease.pdf

  199. BulletTreatment with β blockers in people with COPD.pdf

  200. BulletTroponin ad CCF.pdf

  201. BulletTroponin analysis Edit.pdf

  202. BulletTroponin is superior to electrocardiogram and creatinine kinase MB for predicting clinically significant myocardial injury.pdf

  203. BulletTuberculosis and World War I.pdf

  204. BulletTuberculosis Detection by Giant African Pouched Rats.pdf

  205. BulletTuberculosis review 2013.pdf

  206. BulletTuberculosis Review 2019.pdf

  207. BulletTwelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents.pdf

  208. BulletType 2 diabetes review.pdf

  209. BulletType 2 Myocardial Infarction.pdf

  210. BulletUlcerative colitis review 2012.pdf

  211. BulletUltrafiltration in acute cardiorenal syndrome.pdf

  212. BulletUltrafiltration in Heart Failure.pdf

  213. BulletUnderstanding diastolic heart failure.pdf

  214. BulletUnderstanding myocardial infarction.pdf

  215. BulletUnexpectedly High Recanalization Rate in Patients with Pulmonary Embolism Treated with Anticoagulants Alone.pdf

  216. BulletUnfolding Discoveries in Heart Failure 2020.pdf

  217. BulletUnstable angina review.pdf

  218. BulletUnstable coronary plaques.pdf

  219. BulletUpdate on Lupus Nephritis.pdf

  220. BulletUpper Gastrointestinal Bleeding Due to a Peptic Ulcer review 2016.pdf

  221. BulletUreamia.pdf

  222. BulletValvular heart disease 2018.pdf

  223. BulletVascular access and antithrombotic therapy in patients with acute coronary syndrome.pdf

  224. BulletVasopressin Antagonists Review 2015.pdf

  225. BulletVenous thromboembolism prophylaxis may cause more harm than benefit.pdf

  226. BulletVentricular septal defect Review.pdf

  227. BulletVibration-Controlled Transient Elastography for Diagnosing Cirrhosis and Staging Hepatic Fibrosis.pdf

  228. BulletViral myocarditis.pdf

  229. BulletVon Willebrand Factor — A Rapid Sensor of Paravalvular Regurgitation during TAVR.pdf

  230. BulletVon Willebrand’s Disease Review 2016.pdf

  231. BulletWarfarin in AF Edit.pdf

  232. BulletWeight based IV heparin nomogram.pdf

  233. BulletWeight Gain After Fecal Microbiota Transplantation.pdf

  234. BulletWhat to do now in Heart Failure with Preserved Ejection Fraction.pdf

  235. BulletWhat’s new in cardiorenal syndrome?.pdf

  236. BulletWhat’s new in the Fourth Universal Definition of Myocardial infarction?.pdf

  237. BulletWolff Parkinson White Syndrome.pdf

  238. Bulletβ-Lactams against Tuberculosis.pdf

  1. References


  1. Pod/vodCasts

  1. Presentations

• Other Interesting Sites

MEDIC’S CORNERMedics_Corner.htmlshapeimage_3_link_0